Physician profile
Prashant Kumar
NPI 1073756441
$6,137.75
in general payments reported to CMS, 2019-2025
25 companies · $77.45 in 2025
The $77.45 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,178 · 2020: $630 · 2021: $1,417 · 2022: $860 · 2023: $1,216 · 2024: $760 · 2025: $77.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674 · Travel and Lodging: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.29 |
| Travel and Lodging | $378.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,413.95 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Painteq LLC | $659.74 | 2021-2024 | Painteq |
| Spr Therapeutics, INC | $635.76 | 2020-2025 | Sprint Pns System |
| Medtronic, INC. | $208.53 | 2022-2025 | Intellis Adaptivestim, Venaseal |
| Saluda Medical Americas, INC. | $150.09 | 2024 | Evoke |
| Abbott Laboratories | $122.78 | 2020-2024 | Proclaim, Eterna |
| Nevro Corp. | $120.81 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $115.89 | 2021 | |
| Almatica Pharma LLC | $87.13 | 2021 | |
| Vertos Medical, INC. | $84.04 | 2020-2021 | |
| Medtronic USA, INC. | $82.26 | 2019 | |
| Stryker Corporation | $76.80 | 2020-2022 | |
| Stimwave Technologies Incorporated | $49.65 | 2020-2021 | |
| Shionogi INC | $44.88 | 2019 | |
| Valinor Pharma, LLC | $43.51 | 2023 | Movantik |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $34.51 | 2019 | |
| Amgen INC. | $30.00 | 2021 | |
| Gilead Sciences, INC. | $28.39 | 2021 | |
| Lilly USA, LLC | $24.69 | 2022 | |
| Curonix LLC | $23.45 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $22.96 | 2025 | Senza |
| Assertio Therapeutics, INC. | $20.61 | 2019 | |
| Ucb, INC. | $20.04 | 2019 | |
| Pfizer INC. | $20.01 | 2023 | |
| Fidia Pharma USA INC. | $17.27 | 2023 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashant Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.